De-Risking Next Generation Biologics 2009
CSS
Event Information
Document Title
See Who Attended
as of October 9, 2009
| Job Title | Company |
| Senior Director, Business Development | Adnexus a Bristol Myers Squibb R & D Company |
| Director | Alexion Pharmaceuticals Inc |
| Senior Director of Development | Amplimmune |
| Vice President | Amunix |
| Senior Director | Anaptysbio Inc |
| Vice President, Reimbursement | Avalere Health |
| Chemist | Barr Laboratories Inc |
| Scientist | Baxter Healthcare |
| Vice President of Business Development | Biolex Therapeutics Inc |
| Senior Consultant | Biologics Consulting Group |
| Director | Biotechnology Center of Georgia |
| President | BioTechnology Information Institute |
| Director | Bristol Myers Squibb |
| Director | Celltrion, Inc. |
| Director | Charles River Laboratories |
| Associate Director | CSL Limited |
| Product Manager, New Products | Decision Resources, Inc. |
| Vice President | Defined Health |
| Principal Strategy and Operations | Deloitte Consulting |
| Senior Vice President | Dr. Reddy's Laboratories |
| Consultant, Therapeutic Area Strategy | Eli Lilly & Company |
| President & CEO | Epitomics. Inc. |
| Chief Information Officer | EpiVax Inc |
| Attorney Advisor | Federal Trade Commission |
| Senior Director | Genmab, Inc. |
| Associate Director | GlycoFi Inc |
| Senior Director and Site Head | Glyvofi/Merck & Co. |
| VP, Business Development | GTC Biotherapeutics |
| Vice President of Operations | InSight Biopharmaceuticals Limited |
| Venture Leader, Centyrex | Johnson & Johnson Ventures |
| Professor | KAIST |
| Principal and CEO | Matrix Global Advisors |
| Director | Maxygen Inc |
| Vice President | Merck & Company Inc |
| Executive Director & Head | Merck & Company Inc |
| Senior Investigator Cancer Research | Merck & Company Inc |
| Merck & Company Inc | |
| Research Fellow | Merck & Company Inc |
| Senior Scientist | Merck & Company Inc |
| Senior Director | Merck Research Laboratories |
| Research Scientist | Millipore Corporation |
| Co-Founder and CSO | Momenta Pharmaceuticals |
| Chief Executive Officer | PanGenetics Ltd. |
| Associate Research Fellow | Pfizer, Inc |
| Senior Corporate Counsel | Pfizer, Inc. |
| Executive Director | PharmaNet Development Group Inc |
| Senior Research Analyst | Sanford C. Bernstein |
| Director, Business Development | Scil Proteins GmbH |
| Chief Operating Officer | Shanghai Celgen Biopharmaceuticals |
| Chief Scientific Officer | Shenyang Sunshine Pharmaceuticals (3SBio |
| Founder & Head of Technology Development | Syntaxin Ltd |
| Vice President | Teva Biopharmaceuticals USA Inc |
| Associate Director | Teva Biopharmaceuticals USA Inc |
| Vice President | Teva Pharmaceuticals |
| Director | TikhePharma |
| Director of Project Management | Wyeth |
| Regulatory Specialist | Wyeth |
| President & Chief Executive Officer | Xencor Inc |
| Manager | Xencor Inc |
| Vice President | Xencor, Inc. |
Bottom menu
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved